GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies

We read with interest the recent letter by Ramiro et al 1 reporting data from a systematic literature review on the measurement of enthesitis, dactylitis and nail disease in psoriatic arthritis (PsA) clinical trials. The authors highlight the great variety in the outcome measures chosen, cut points...

Полное описание

Библиографические подробности
Главные авторы:	Tillett, W, Orbai, A, Ogdie, A, Leung, Y, Strand, V, Gladman, D, Mease, P, Coates, L
Формат:	Journal article
Язык:	English
Опубликовано:	BMJ Publishing Group 2017

Схожие документы

Initiating evaluation of composite outcome measures for psoriatic arthritis: 2022 updates from the GRAPPA-OMERACT Working Group
по: Leung, Y-Y, и др.
Опубликовано: (2023)

Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiative
по: Antony, A, и др.
Опубликовано: (2021)

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 annual meeting: report and plan for completing the core outcome measurement set
по: Leung, Y, и др.
Опубликовано: (2019)

The GRAPPA-OMERACT Working Group: 4 prioritized domains for completing the core outcome measurement set for psoriatic arthritis 2019 updates
по: Leung, YY, и др.
Опубликовано: (2020)

Effect of secukinumab on the different GRAPPA-OMERACT core domains in psoriatic arthritis: a pooled analysis of 2049 patients
по: Orbai, A-M, и др.
Опубликовано: (2019)

Content and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting
по: Holland, R, и др.
Опубликовано: (2018)

Classification and outcome measures for psoriatic arthritis
по: Leung, Y, и др.
Опубликовано: (2018)

Outcomes of the 2019 GRAPPA workshop on continuous composite indices for the assessment of psoriatic arthritis and membership: Recommended next steps
по: Tillett, W, и др.
Опубликовано: (2020)

OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF
по: Leung, Y-Y, и др.
Опубликовано: (2021)

Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity: OMERACT 2018 psoriatic arthritis workshop report
по: Duarte-García, A, и др.
Опубликовано: (2019)

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis
по: Coates, L, и др.
Опубликовано: (2017)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
по: Soriano, ER, и др.
Опубликовано: (2023)

Appraisal of candidate instruments for assessment of the physical function domain in patients with psoriatic arthritis
по: Leung, YY, и др.
Опубликовано: (2020)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
по: Coates, LC, и др.
Опубликовано: (2022)

PsAID12 provisionally endorsed at OMERACT 2018 as core outcome measure to assess psoriatic arthritis-specific health-related quality of life in clinical trials
по: Orbai, A, и др.
Опубликовано: (2018)

The benefits and challenges of setting up a longitudinal psoriatic arthritis database
по: Gladman, DD, и др.
Опубликовано: (2018)

Psoriatic arthritis
по: FitzGerald, O, и др.
Опубликовано: (2021)

Measuring outcomes in psoriatic arthritis
по: Ogdie, A, и др.
Опубликовано: (2020)

The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: similarities and differences
по: Coates, L, и др.
Опубликовано: (2022)

Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review
по: Leung, Y-Y, и др.
Опубликовано: (2020)

Test-retest reliability for HAQ-DI and SF-36 PF for the measurement of physical function in psoriatic arthritis
по: Leung, YY, и др.
Опубликовано: (2021)

Inhibition of interleukin-17 in patients with oligoarticular psoriatic arthritis
по: Ogdie, A, и др.
Опубликовано: (2023)

New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation
по: Coates, L, и др.
Опубликовано: (2016)

GRAPPA 2018 project report
по: Goel, N, и др.
Опубликовано: (2019)

GRAPPA 2017 Project Report
по: Callis Duffin, K, и др.
Опубликовано: (2018)

Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative
по: De Marco, G, и др.
Опубликовано: (2020)

Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
по: Alexis Ogdie, и др.
Опубликовано: (2023-05-01)

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
по: Poddubnyy, D, и др.
Опубликовано: (2021)

GRAPPA 2019 project report
по: Goel, N, и др.
Опубликовано: (2020)

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
по: Denis Poddubnyy, и др.
Опубликовано: (2021-12-01)

Psoriatic arthritis: prospects for the future
по: Hackett, S, и др.
Опубликовано: (2022)

GRAPPA 2016 Project Report
по: Helliwell, P, и др.
Опубликовано: (2017)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
по: Helliwell, PS, и др.
Опубликовано: (2022)

A presença da reumatologia brasileira no GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) The presence of the Brazilian rheumatology in the GRAPPA
по: Cláudia Goldenstein-Schainberg, и др.
Опубликовано: (2011-10-01)

Measurement properties of the minimal disease activity criteria for psoriatic arthritis
по: Coates, L, и др.
Опубликовано: (2019)

Proceedings of the GRAPPA 2022 executive retreat
по: Ng, B, и др.
Опубликовано: (2023)

Management of dactylitis in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations
по: Palominos, PE, и др.
Опубликовано: (2022)

Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project
по: Philip J Mease, и др.
Опубликовано: (2024-02-01)

Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR)
по: Orbai, A-M, и др.
Опубликовано: (2019)

Psoriatic arthritis: prospects for the future
по: Simon Hackett, и др.
Опубликовано: (2022-03-01)